An official congressional financial disclosure shows Richard Blumenthal (Senate Democrat) reported a $15K–$50K sale of $STLN (Starling Oncology, Inc.), with a transaction date of 2026-09-18.
The trade became public on 2026-10-26, 38 days after it was made.
It is the 5th disclosure this member has filed in $STLN.
A financial disclosure is a public record filed under the STOCK Act, not evidence of wrongdoing. Amounts are reported as ranges, and any figures here are drawn from official filings. This is a transparency record, not investment advice.